News & Events
A new study fails to replicate the role of a gene in developing primary progressive MS
A retrospective study of rituximab use in MS shows evidence for its safety and effectiveness
People with MS display increased deficiencies in social cognition
People from countries with higher latitudes are found to have an earlier onset of MS
Study shows alemtuzumab can improve pre-existing disability in relapsing-remitting MS
Earlier this month our CEO Peer Baneke and Head of Capacity Building Zoe Burr travelled to Buenos…
For the last 19 years the MS Society of India’s Chennai Chapter has marked the 'Month of…
MS Australia joined forced with other organisations to recognise caregivers
MSIF’s Evelyn Nicholson award helps to recognise the importance of volunteer caregivers in the MS community
We’re collecting resources for caregivers from around the world
Researchers assess whether changes in the retina can be used as a marker of MS activity
Study shows that alemtuzumab is more effective than interferon in reducing disease activity in relapsing remitting MS